en · de · es · fr · pt
cjc-1295-notes.peptides6608.com › Data › Background And Receptor Mechanism — Hands-On Walkthrough

Background And Receptor Mechanism — Hands-On Walkthrough

By Editorial Desk · published 2026-02-15 · last reviewed 2026-03-14 · Data

This is a working overview of Albumin conjugation, written for readers who want more than a one-paragraph summary but less than a textbook.

This page was last updated on 2026-03-14 and is reviewed periodically as new material appears.

Background and Receptor Mechanism

CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.

Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.

At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.

CJC-1295 Structure And Mechanism

The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.

Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.

Cjc-1295 at a glance

PropertyValueNotes
Molecular weight, DAC formAbout 3647 DaVaries with salt form
Molecular weight, non-DAC formAbout 3358 DaMOD GRF(1-29)
Solubility classWater solubleAlso dissolves in polar solvents
Reported half-life, DAC formAbout five to eight daysValues from human studies
Common synonymsCJC-1295; MOD GRF(1-29)Name depends on variant

Handling, Stability and Analysis

Reported half-lives differ widely between the two variants and between species. Values for the albumin-binding form are usually expressed in days, while the unconjugated form is measured in minutes to a few hours. Sampling schedules, assay sensitivity, and route of administration all influence the numbers, which limits direct comparison across studies. Whether sustained receptor occupancy produces different downstream effects from pulsatile stimulation remains an open question in the published work. Claims about relative potency should therefore be read alongside the specific study design that produced them.

Lyophilised powder is the usual supplied form. The material is hygroscopic, so vials are typically equilibrated to room temperature before opening in order to prevent condensation on the contents. Long-term storage is generally described at minus twenty degrees Celsius or colder, protected from light and moisture. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of soluble material. A reconstituted solution is considerably less stable than the dry powder and is normally kept refrigerated for short periods only.

Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography combined with mass spectrometry. The chromatographic separation resolves the target peptide from truncation products and from species carrying oxidised residues, while mass measurement confirms the expected molecular mass. Because the two common variants differ by roughly 280 daltons, a mass determination distinguishes them unambiguously. Purity is often quoted as a percentage of total peak area, although that figure depends on the detection wavelength and the integration method applied.

Related pages on this site

Molecular Background and Naming

The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.

CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.

Background and Molecular Design

CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.

Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.

The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.

Further detail

Venous access is any method used to access the bloodstream through the veins, either to administer intravenous therapy such as medication, or fluid, parenteral nutrition, to obtain blood for analysis, or to provide an access point for blood-based treatments such as dialysis or apheresis. Access is most commonly achieved via the placement of a central venous catheter, a Seldinger technique, and guidance tools such as ultrasound and fluoroscopy can also be used to assist with access location.

=== Other benefits === Pre-workout has shown to make athletes feel more energetic during exercise, but the higher energy levels are based on subjective judgement and there is little quantitative proof of an increase in energy. Caffeine's role in enhancing the improvement in perceived energy is observed through the large amounts of caffeine typically found in pre-workout supplements. Caffeine also increases calcium release which allows for stronger muscle contractions during high intensity workouts. Studies also show that the caffeine in pre-workout improves focus and alertness in athletes as observed through a decrease in reaction-time in different settings.

The two substrates of this enzyme are (R,R)-butane-2,3-diol and NAD+; its products are (R)-acetoin, nicotinamide adenine dinucleotide (NADH), and a proton. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is (R,R)-butane-2,3-diol:NAD+ oxidoreductase. Other names in common use include butyleneglycol dehydrogenase, D-butanediol dehydrogenase, D-(−)-butanediol dehydrogenase, butylene glycol dehydrogenase, diacetyl (acetoin) reductase, D-aminopropanol dehydrogenase, D-aminopropanol dehydrogenase, 1-amino-2-propanol dehydrogenase, 2,3-butanediol dehydrogenase, D-1-amino-2-propanol dehydrogenase, (R)-diacetyl reductase, (R)-2,3-butanediol dehydrogenase, D-1-amino-2-propanol:NAD+ oxidoreductase, 1-amino-2-propanol oxidoreductase, and aminopropanol oxidoreductase. This enzyme participates in butanoic acid metabolism.

Basophils appear in many specific kinds of inflammatory reactions, particularly those that cause allergic symptoms. Basophils contain anticoagulant heparin, which prevents blood from clotting too quickly. They also contain the vasodilator histamine, which promotes blood flow to tissues. They can be found in unusually high numbers at sites of ectoparasite infection (e.g. ticks). Like eosinophils, basophils play a role in both parasitic infections and allergies. They are found in tissues where allergic reactions are occurring and probably contribute to the severity of these reactions. Basophils have protein receptors on their cell surface that bind IgE, an immunoglobulin involved in macroparasite defense and allergy. It is the bound IgE antibody that confers a selective response of these cells to environmental substances (e.g., pollen proteins or helminth antigens). Recent studies in mice suggest that basophils may also regulate the behavior of T cells and mediate the magnitude of the secondary immune response.

Sources: en.wikipedia.org

Background from the literature

== Causes == DEB is caused by genetic defects (or mutations) within the human COL7A1 gene encoding the protein type VII collagen (collagen VII). DEB-causing mutations can be either dominant or recessive. Most families with family members with this condition have distinct mutations. Collagen VII is a very large molecule (300 kDa) that dimerizes to form a semicircular looping structure: the anchoring fibril. Anchoring fibrils are thought to form a structural link between the epidermal basement membrane and the fibrillar collagens in the upper dermis.

RBR and HBR were defined in the initial release of the DisplayPort standard, version 1.0 HBR2 was introduced in version 1.2 HBR3 was introduced in version 1.3 UHBR10, UHBR13.5, and UHBR20 were introduced in version 2.0 However, transmission mode support is not necessarily dictated by a device's claimed "DisplayPort version number". For example, older versions of the DisplayPort Marketing Guidelines allowed a device to be labeled as "DisplayPort 1.2" if it supported the MST feature, even if it didn't support the HBR2 transmission mode. Newer versions of the guidelines have removed this clause, and currently (as of the June 2018 revision) there are no guidelines on the usage of DisplayPort version numbers in products. DisplayPort "version numbers" are therefore not a reliable indication of what transmission speeds a device can support. In addition, individual devices may have their own arbitrary limitations beyond transmission speed. For example, NVIDIA Kepler GK104 GPUs (such as the GeForce GTX 680 and 770) support "DisplayPort 1.2" with the HBR2 transmission mode, but are limited to 540 Mpx/s, only 3⁄4 of the maximum possible with HBR2. Consequently, certain devices may have limitations that differ from those listed in the following tables. To support a particular format, the source and display devices must both support the required transmission mode, and the DisplayPort cable must also be capable of handling the required bandwidth of that transmission mode. (See: Cables and connectors)

=== Intrinsically disordered proteins === Using a method for the rapid and multiplexed gene synthesis of repetitive polypeptides, Chilkoti created new variants of ELPs that show phase separation. He then built upon these findings to identify new sequence heuristics that enable the de novo design of repetitive polypeptides that show LCST and UCST phase behavior. He postulated that the low sequence complexity, structural disorder, and phase separation behavior of these repetitive polypeptides make them an interesting class of minimal synthetic intrinsically disordered proteins IDPs (synIDPs), and suggested that these SynIDPs can provide insights into the behavior of other more complex, native IDPs. His group has started to exploit the phase transition behavior of two classes of SynIDPs—ELPs that exhibit LCST phase behavior and resilin-like polypeptides (RLPs) that exhibit UCST phase behavior—to create artificial condensates within cells whose material properties and function can be precisely programmed at the sequence level of the SynIDP to reprogram cellular function by spatio-temporally controlling the flow genetic information and biochemical signals within the cell. His later work on functional artificial condensates of SynIDPs in cells includes sequestration of mRNA in a condensate regulate protein translation, sequestration of an enzyme in an artificial condensate to amplify its activity, sequestration of a plasmid to control gene flow in bacteria and recruitment of the transcriptional machinery to amplify gene expression.

Revenues in the world liquid chromatography market, specifically, are expected to grow from $3.4 billion in 2007 to $4.7 billion in 2013, with a slight decrease in spending expected in 2008 and 2009 from the worldwide economic slump and decreased or stagnant spending. The pharmaceutical industry alone accounts for 35% of all the HPLC instruments in use. The main source of growth in LC stems from biosciences and pharmaceutical companies.

Looking at HM Prison Deerbolt in County Durham and Maudsley Hospital in South London, and divorce and one-parent families had different effects; Iain Duncan Smith talks of being 'victims in society of a social experiment over many decades'; Jonathan Sacks, Baron Sacks talking of a 'national consensus that something was missing in the moral environment'; there was a belief that juvenile crime was linked to single parents and broken homes; Michael Anderson, Professor of Economic History at the University of Edinburgh, claimed that it was all due to current politicians wanting to nostalgically return to a 'golden age' of civility, and he inferred that 'Victorian values' had no importance; a training session for single parents in Maudsley Hospital in Southwark; Michael Wadsworth (sociologist) and the National Survey of Health & Development, which had around 5,000 on the cohort study, and had been set up for establishing the NHS - it showed that divorce increased chances of divorce in children, and of delinquency in children; Martin Richards (psychologist) of the University of Cambridge's Centre for Family Research, and the 1958 National Child Development Study, which looked all of the 17,000 born in one week in early March, and showed similar results to the previous study; the Marriage Research Centre began a study of 65 married couples in 1979; Penny Mansfield CBE of OnePlusOne said that women, after entering the workplace in greater numbers, were now having higher expectations of men's contribution to a marriage; the divorce rate was now 40%, with 33% of divorces occurring in the first five years of marriage; lone parents were now 19% of all British families; for children of divorced parents, 95% would stay with the mother, and within two years, 50% of these children would lose contact totally with their father; Prof John Newson, husband of Elizabeth Newson, and the Child Development Research Unit, founded in 1958 at the University of Nottingham - he said that juvenile delinquency was heavily related to the lower social classes - for the bottom two social classes, one quarter of the children receive a criminal record; David P. Farrington and Donald J. West of the University of Cambridge, conducted a study of 400 London boys born in 1953, known as the Cambridge Study in Delinquent Development; in the study, 37% of all boys acquired a criminal record, but of those with three known determining factors, 75% had a criminal record; 50% of the crime in the study was conducted by only 22 boys, 6% of the total; a study had taken place from 1962 to 1967 in Ypsilanti, Michigan on early years education; similar schemes in the UK were called Head Start, and the main project in the UK was HighScope, with a few schemes at primary schools funded by the Home Office. Directed by Richard Denton, produced by Geoff Deehan, made by Union Pictures 10 October In the Path of a Killer Volcano, with seismologists Dave Harlow, Richard Hoblitt, and John Ewert of the United States Geological Survey; although the biggest volcanic explosion since Krakatoa was about to occur, the seismologists at Philippine Institute of Volcanology, and Seismology (PHIVOLCS) and its director Ray Punongbayan, were mostly totally unaware of anything that abnormal; PHIVOLCS put a seismometer near the volcano, and it recorded over 400 earthquakes in just two days near the summit, so Ray Punongbayan requested urgent assistance from the US Geological Survey; Clark Air Base and U.S. Naval Base Subic Bay were around ten miles away, so seven seismic stations were in place by early May; a helicopter was flown around the site and air samples were taken for a correlation spectrometer to detect any sulphur dioxide, with the ultraviolet; Christopher G. Newhall described how sulphur dioxide detection went from 500 tonnes a day to 5000 tonnes by the end of the month; Mount Katmai in Alaska had been the 20th Century's largest volcanic explosion in early June 1912; a level-4 volcanic event is declared two days before the eruption and 120,000 people are evacuated from a 12-mile radius, but the USAF don't feel the immediate need to move; in only that same week, an eruption had been watched on Mount Unzen in Japan, and its pyroclastic flow, but those scientists who felt apparently safe when watching at close hand were caught out when the flow unexpectedly changed direction and they were trapped and were burned to death; on the morning of 10 June, the USAF base was evacuated 48 hours before the first eruption on 12 June, but the main eruption took place three days later on 15 June, with most of the scientists at the USAF base; the mud flows, known as lahar, caused the most damage by filling rivers so causing many floods; the cloud of debris would circle the globe, and reduced global average temperature by one degree over five years; the 1985 eruption of Nevado del Ruiz in Colombia had led to the Armero tragedy, killing more than 20,000 of the town's 29,000 as the eruption was not forecast. Originally a Nova documentary made in 1992, also produced by Paula S. Apsell, a joint British-American production, produced by Noel Buckner, made by WGBH

Sources: en.wikipedia.org

Frequently asked questions

What is CJC-1295?

It is a synthetic peptide modeled on growth hormone-releasing hormone. The molecule is used in research on pituitary growth hormone secretion. It differs from the natural hormone through several stabilizing substitutions.

How do the DAC and non-DAC forms differ?

The DAC form carries a maleimide group that binds albumin and extends circulation time. The non-DAC form lacks this group and clears much faster. Both share the same receptor-binding core.

What receptor does it act on?

It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Activation raises cyclic AMP and promotes growth hormone release. Normal feedback pathways remain part of the response.

How does CJC-1295 differ from modified GRF(1-29)?

The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.

Network